Bill Title: Expressing the sense of the House of Representatives that the Food and Drug Administration should encourage the use of abuse-deterrent formulations of drugs.

Sponsorship: Bipartisan Bill

Status: (Introduced - Dead) 2013-04-19 - Referred to the Subcommittee on Health. [HR161 Detail]

---

Bill Drafts

Revision	Date	Format	Source	View
Introduced	2013-04-16	PDF	Link	View

Amendments

Amendment	Date	Disposition	Format	Source	View
No bill amendments currently on file for US Congress HR161

Supplemental Documents

Title	Description	Date	Format	Source	View
No supplemental documents for US Congress HR161 currently on file.